Mitsubishi, Janssen Seek To Block Generic Diabetes Drug
Mitsubishi Tanabe Pharma and the licensees of its diabetes drug Invokamet XR have hit generic-drug manufacturer Aurobindo Pharma USA with a patent infringement suit in New Jersey federal court over what...To view the full article, register now.
Already a subscriber? Click here to view full article